FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns chemical pharmaceutical industry, particularly medicine for treatment of virus diseases, including HIV infection (AIDS and HIV-related diseases). The antiviral medicine is a 1% ointment containing fullerene-polyhydropolyaminocaproic acid as active substance and auxiliary substances of dimethylsulfoxide, water-free lanolin and Vaseline in the following amount (g): fullerene-polyhydropolyaminocaproic acid 1.0, diemthylsulfoxide 10.0, water-free lanolin 10.0, Vaseline up to 100.0.
EFFECT: obtaining antiviral medicine for treatment of virus diseases, including HIV infection.
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL MEDICINE | 2007 |
|
RU2333751C1 |
| ANTIVIRAL MEDICINE | 2007 |
|
RU2333753C1 |
| HYDRATED N-FULLERENE-AMINO ACID DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458046C1 |
| HOMO- AND HETERO-POLYAMINO ACID FULLERENE C DERIVATIVES, METHOD FOR PREPARING THEM AND BASED PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2458914C1 |
| ANTI-VIRAL AGENT | 2006 |
|
RU2316320C1 |
| ANTI-VIRAL AGENT FOR SYSTEMIC APPLICATION | 2006 |
|
RU2316321C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HERPES VIRAL INFECTION | 2003 |
|
RU2241443C1 |
| COMPLEX ANTIVIRAL MEDICATION FOR EXTERNAL APPLICATION IN TREATMENT OF HERPES VIRUS INFECTIONS | 2010 |
|
RU2438697C1 |
| AGENT FOR EXTERNAL USE WITH ANTIVIRAL ACTION | 2021 |
|
RU2819719C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF GENITAL HERPES, CHRONIC PAPILLOMA OF VIRAL INFECTION AND PROPHYLAXIS OF UTERINE CERVIX CANCER (VARIANTS) | 2000 |
|
RU2180593C1 |
